How do I peer respond to Kiley and ask a question:

Hello everyone,

Pfizer creates value for its customers by leveraging innovation, research, and global reach to develop and distribute life-saving medications and vaccines. Through sustained investment in research and development (R&D), Pfizer delivers treatments that address critical health challenges across areas such as oncology, immunology, cardiology, and infectious diseases. This innovation-driven strategy supports both product differentiation and therapeutic effectiveness, increasing value for patients, healthcare providers, and public health systems (Pfizer, 2023). Additionally, their global supply chain and commitment to affordability programs, like patient assistance initiatives, further enhance its value proposition.

However, the line between transparent, legitimate practices and ethical dilemmas in the pharmaceutical industry is often blurred. For example, while marketing drugs directly to consumers or doctors can increase awareness, it may also lead to over prescription or influence decision-making in ways that do not fully align with patient needs. Ethical dilemmas can arise in clinical trials, such as decisions about placebo use or global testing practices in low-income regions. These practices can test the balance between transparency, profitability, and social responsibility (Rodwin, 2021).

BI analysis plays a significant role in helping Pfizer and other organizations allocate resources effectively during decision-making processes. By leveraging real-time data, predictive analytics, and key performance indicators, BI tools enable strategic insights into market trends, R&D productivity, and supply chain efficiency. This allows for targeted resource distribution that maximizes impact and minimizes waste. For example, Pfizer uses data-driven forecasting to prioritize vaccine distribution, ensuring higher availability in regions with urgent demand. Overall, BI strengthens strategic alignment, improves risk management, and supports ethical, patient-focused outcomes.

References:

Pfizer. (2023). Innovation: The core of what we do. https://www.pfizer.com/science

Rodwin, M. A. (2021). Conflicts of interest, institutional corruption, and pharma: An agenda for reform. Journal of Law, Medicine & Ethics, 49(3), 352-363. https://doi.org/10.1017/jme.2021.48

-Kiley